TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By The Schall Law Firm
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm

The Schall Law Firm is investigating CVS Health Corporation's Aetna Medicare Advantage plans for potentially wrongfully denying prior authorizations for post-acute care using artificial intelligence without proper medical professional review, as required by contracts. The investigation covers claims from November 2019 to present, and CVS's AI practices have recently drawn scrutiny from the U.S. Senate.

Insights
RGTIW   negative

CEO selling stock, primarily in R&D phase, years away from meaningful revenue


CVS   negative

CVS is the subject of a formal investigation by a national litigation firm for allegedly breaching contracts by using AI to deny post-acute care claims without required medical professional review. The conduct has drawn U.S. Senate scrutiny, indicating potential regulatory and legal risks.